new controversies in the management of gastrointestinal … · 2015. 2. 5. · in the management of...
Post on 25-Sep-2020
0 Views
Preview:
TRANSCRIPT
March 21, 2015The Umstead Hotel and SpaCary, North Carolina
Duke Debates:Controversies In The Management of Gastrointestinal Malignancies
THE DUKE CANCER NETWORK in conjuction with THE DUKE CANCER INSTITUTE PRESENTS
Du
ke D
ebat
es:
Con
trov
ersi
es In
The
Man
agem
ent
of
Gas
troi
ntes
tinal
Mal
igna
ncie
s
Mar
ch 2
1, 2
015
REG
ISTR
ATI
ON
Reg
iste
r on
line
at h
ttp
://g
oo
.gl/
b4p
faH
$150
MD
$10
0 nu
rse/
fello
w/m
idle
vel
$60
0 in
dust
ry
CO
NTA
CT/
QU
ESTI
ON
S Fo
r qu
estio
ns, p
leas
e co
ntac
t:Be
th T
anne
r at
919
-681
-986
9 or
be
th.t
anne
r@dm
.duk
e.ed
u
HO
TEL
The
Um
stea
d H
ote
l an
d S
pa
100
Woo
dlan
d Po
nd D
rive
Phon
e: 9
19-4
47-4
00
0 C
ary,
NC
275
13
Toll-
free
: 866
-877
-414
1
THE
DU
KE
CA
NC
ER N
ETW
OR
K IN
CO
NJU
CTI
ON
WIT
H
THE
DU
KE
CA
NC
ER IN
STIT
UTE
PR
ESEN
TS
Duk
e C
ance
r N
etw
ork
DU
MC
332
6 D
urha
m, N
C 2
7710
Non
pro
fit O
rg.
U.S
. Pos
tage
PAID
Dur
ham
NC
Perm
it #6
0
Sponsored by the Duke University School of Medicine.
OVERVIEWLearn the most recent innovations in the treatment of gastroesopha-geal cancer, pancreatic cancer, neuroendocrine cancer and colorectal cancer. Discuss the technical aspects of challenging treatment with expert faculty.
AUDIENCEThis program is designed to meet the continuing education needs of oncologists, physician extenders, and allied health professionals.
LEARNING OBJECTIVES• Discuss multidisciplinary approaches for the management of
gastroesophageal cancer
• Discuss multidisciplinary approaches for treatment of neuroendocrine cancers
• Discuss multidisciplinary approaches for treatment of localized and advanced pancreatic cancer
• Identify molecular testing strategies and approaches for treatment of metastatic colorectal cancer
7:30 am Registration/Breakfast
8:00 am Welcome
8:05 am Key Note Speaker: Metastatic Pancreatic Cancer: Have Our Trials Failed Us or Have We Failed Our Patients? Jordan Berlin, MD, Ingram
Professor of Cancer Research, Vanderbilt University
9:00 am Case Presentation with Audience Response
9:10 am DEBATE: Management of Resected Gastroesophageal Cancer Hope Uronis, MD* vs.
Niharika Mettu, MD, PhD*
10:00 am Break
10:15 am Controversies and Challenges in GI Pathology for the Medical Oncologist Shannon McCall, MD*
11:05 am Case Presentation with Audience Response
11:15 am DEBATE: How I Treat Asymptomatic, Advanced Neuroendocrine Cancer Michael Morse, MD, MHS*
vs. Gerard Blobe, MD, PhD*
12:05 pm Lunch
1:05 pm Case Presentation with Audience Response
1:15 pm DEBATE: Is There a Role for Radiation in Localized Pancreatic Cancer? James Abbruzzese, MD*
vs. Brian Czito, MD*
2:05 pm Case Presentation with Audience Response
2:15 pm DEBATE: Is There a Role for HIPEC in Colorectal Cancer? Dan Blazer III, MD* vs.
David Hsu, MD, PhD*
3:05 pm Break
3:20 pm Case Presentation with Audience Response
3:30 pm Panel Discussion: Challenging Case of Colorectal Cancer Drs. Herbert Hurwitz*, John
Strickler* and Ivy Altomare*
4:20 pm Conclusion
*Duke University Faculty
Course Co-Directors
S. Yousuf Zafar, MD, MHS Assistant Professor of Medicine, Duke University Health System
Ivy Altomare, MD Associate Professor of Medicine, Duke University Health System
Linda Sutton, MD Associate Professor of Medicine, Medical Director, Duke Cancer Network Associate Chief Medical Officer, Duke Network Services
ACCREDITATION: In support of improving patient care, Duke Medicine is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
Duke Medicine designates this live educational activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The CPE Review Panel has approved the proposed agenda “Duke Debates: Controversies in the Management of Gastrointestinal Malignancies” to be presented March 21, 2015 for 6.5 hours of credit. Your Program ID# is NCNC03211504
RESOLUTION OF CONFLICTS OF INTEREST: In accordance with the ACCME Standards for Commer-cial Support of CME, the Duke University School of Medicine will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
DISCLAIMER: The information provided at this CME activity is for continuing medical education purposes only and is not meant to substitute the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
COMMERCIAL SUPPORT: A complete list of supporters will be provided to attendees during the event.
Sponsored by the Duke University School of Medicine
AGENDA SATURDAY, MARCH 21, 2015
top related